The US Food and Drug Administration authorised the utilization of Pfizer-BioNTech's Covid-19 vaccine, with the primary inoculations expected in under 24 hours, marking a turning point within the us where the pandemic has killed quite 292,000 people.The FDA granted an emergency use authorisation for the vaccine, developed with German partner BioNTech, which was shown to be 95% effective in preventing the disease in a late-stage trial.
US President Donald Trump said that the primary shot would be administered within the US in but 24 hours.The FDA said the vaccine can be given to people aged 16 and older.
Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses.
Mexico approves emergency use of Pfizer's vaccine Mexican health regulator Cofepris has approved the emergency use of Pfizer's Covid-19 vaccine, deputy health minister Hugo Lopez-Gatell said.
Mexico has registered 12,253 new confirmed cases of coronavirus infection and 693 additional fatalities, bringing the total in the country to 1,229,379 cases and 113,019 deaths.
China reports 13 new cases China has reported 13 new coronavirus cases in the mainland for December 11, down from 15 cases a day earlier, the health commission said. All of the new cases were imported infections originating from abroad, consistent with a press release by the National Health Commission.
The number of latest asymptomatic cases, which China doesn't classify as confirmed cases, rose to 17 compared to seven each day earlier. As of Friday, mainland China had 86,701 confirmed coronavirus cases, the health authority said. The Covid-19 death toll remained at 4,634.
US secures access to 100M more doses of Moderna's vaccine Moderna Inc has said that the US government will get an additional 100 million doses of its Covid-19 vaccine candidate, expected to be delivered in the second quarter of 2021 if authorised. Shares of the company were up 2.8 percent at $161.30 after the bell.
The government has ordered a complete of 200 million doses so far , the vaccine developer said, adding that of the primary order lot, about 20 million doses are going to be delivered by December end and the remaining in the first quarter of 2021. The us in August entered an agreement with Moderna to accumulate 100 million doses of its potential Covid-19 vaccine for around $1.5 billion, with an choice to secure an additional 400 million doses. A panel of out of doors advisers to the US Food and Drug Administration is scheduled to carry a gathering on December 17 to debate Moderna's request for emergency use authorisation (EUA) for its vaccine. Meanwhile, the FDA is expected to issue an EUA for Pfizer Inc and partner BioNTech SE's two-dose Covid-19 vaccine as soon as Friday, according to the New York Times.
South Korea reports 950 new cases, highest daily rise South Korea has reported a record daily increase in novel coronavirus cases since the country's first case was confirmed in January, with 950 new infections, the Korea Disease Control and Prevention Agency (KDCA) said.
Of the new cases, 928 were locally transmitted, which bring the entire tally to 41,736 infections, with 578 deaths.
Brazil's death toll tops 180,000
Brazil has reported 53,030 additional confirmed cases of the novel coronavirus within the past 24 hours and 646 deaths from Covid-19, consistent with the Health Ministry.
The South American country has now registered 6,834,829 cases since the pandemic began, while the official death toll has risen to 180,411, according to ministry data. Brazil has the world's second-highest death toll behind the United States and the third highest case count behind the United States and India.
Cuomo reinstates NYC indoor dining ban
Indoor dining at ny City restaurants are going to be banned again in an attempt to halt the coronavirus resurgence, Gov Andrew Cuomo said in an announcement that would foretell a grim winter for one among the city's most vital industries.
The US Food and Drug Administration authorised the utilization of Pfizer-BioNTech's Covid-19 vaccine, with the primary inoculations expected in under 24 hours, marking a turning point within the us where the pandemic has killed quite 292,000 people.The FDA granted an emergency use authorisation for the vaccine, developed with German partner BioNTech, which was shown to be 95% effective in preventing the disease in a late-stage trial.
US President Donald Trump said that the primary shot would be administered within the US in but 24 hours. The FDA said the vaccine can be given to people aged 16 and older.
Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses. Mexico approves emergency use of Pfizer's vaccine
Mexican health regulator Cofepris has approved the emergency use of Pfizer's Covid-19 vaccine, deputy health minister Hugo Lopez-Gatell said. Mexico has registered 12,253 new confirmed cases of coronavirus infection and 693 additional fatalities, bringing the total in the country to 1,229,379 cases and 113,019 deaths. China reports 13 new cases China has reported 13 new coronavirus cases in the mainland for December 11, down from 15 cases a day earlier, the health commission said.
All of the new cases were imported infections originating from abroad, consistent with a press release by the National Health Commission. The number of latest asymptomatic cases, which China doesn't classify as confirmed cases, rose to 17 compared to seven each day earlier.
As of Friday, mainland China had 86,701 confirmed coronavirus cases, the health authority said. The Covid-19 death toll remained at 4,634. US secures access to 100M more doses of Moderna's vaccine
Moderna Inc has said that the US government will get an additional 100 million doses of its Covid-19 vaccine candidate, expected to be delivered in the second quarter of 2021 if authorised.
Shares of the company were up 2.8 percent at $161.30 after the bell. The government has ordered a complete of 200 million doses so far , the vaccine developer said, adding that of the primary order lot, about 20 million doses are going to be delivered by December end and the remaining in the first quarter of 2021. The us in August entered an agreement with Moderna to accumulate 100 million doses of its potential Covid-19 vaccine for around $1.5 billion, with an choice to secure an additional 400 million doses.
A panel of out of doors advisers to the US Food and Drug Administration is scheduled to carry a gathering on December 17 to debate Moderna's request for emergency use authorisation (EUA) for its vaccine. Meanwhile, the FDA is expected to issue an EUA for Pfizer Inc and partner BioNTech SE's two-dose Covid-19 vaccine as soon as Friday, according to the New York Times.
South Korea reports 950 new cases, highest daily rise
South Korea has reported a record daily increase in novel coronavirus cases since the country's first case was confirmed in January, with 950 new infections, the Korea Disease Control and Prevention Agency (KDCA) said. Of the new cases, 928 were locally transmitted, which bring the entire tally to 41,736 infections, with 578 deaths. Brazil's death toll tops 180,000 Brazil has reported 53,030 additional confirmed cases of the novel coronavirus within the past 24 hours and 646 deaths from Covid-19, consistent with the Health Ministry.The South American country has now registered 6,834,829 cases since the pandemic began, while the official death toll has risen to 180,411, according to ministry data. Brazil has the world's second-highest death toll behind the United States and the third highest case count behind the United States and India.
Cuomo reinstates NYC indoor dining ban
Indoor dining at ny City restaurants are going to be banned again in an attempt to halt the coronavirus resurgence, Gov Andrew Cuomo said in an announcement that would foretell a grim winter for one among the city's most vital industries.
{With input from news agency language) If you like this story, share it with a friend!
We are a non-profit organization. Help us financially to keep our journalism free from government and corporate pressure.
0 Comments